Skip to content
value.today

Cormatrix Cardiovascular Inc.

Total raised
$26 M
2 rounds on record
Latest round
$1 M
Oct 2014
First round on record
Jul 2011
Today
Private
No later event on record

Funding rounds

2 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Cormatrix Cardiovascular Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Oct 2014$1 MNo. 2Under $2 million

Cormatrix Cardiovascular Inc.: Raise no. 2, Oct 2014

Investors in this round

2 investors had bought by the notice of Jan 16, 2015: 2 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$1 M of $25 M offered; $24 M still to sell
Smallest investment taken
$500,000
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
$5 million to $25 million
Sales commissions
$1,500,000
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks sales commissions as estimates
The company
Corporation, incorporated in Georgia

People named in the notice

  • Beecher Chewing Lewis · Executive Officer, Director
  • David Bannerman Camp · Executive Officer, Director, Promoter
  • John Cornelius Thomas · Executive Officer, Director
  • Robert Gordon Matheny · Executive Officer, Director, Promoter
  • Blane Horton Crutchfield · Director
  • Jason M Aryeh · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Newport Coast Securities (CRD 16944) · broker-dealer Newport Coast Securities (CRD 16944) · New York, New YorkSold in all US states

Remarks in the notice

  • On fees: “Based on estimated broker sales of $25M, cash commission of 6% of investment plus warrants covering shares equal to 6% of number of shares sold.”

Signed by John C. Thomas, Secretary. Source: SEC Form D, newest notice filed Jan 16, 2015. Read the notice at the SEC.

equitySEC
Jul 2011$25 MNo. 1$10 to $50 million

Cormatrix Cardiovascular Inc.: Raise no. 1, Jul 2011

Investors in this round

34 investors had bought by the notice of Oct 15, 2013: 34 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$25 M of $25 M offered; $0 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
more than a year
Issuer's revenue
$5 million to $25 million
Sales commissions
none
Finders' fees
$1,119,502
Paid to its own people
$702,000 (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Georgia

People named in the notice

  • Beecher Chewing Lewis · Executive Officer, Director
  • David Bannerman Camp · Executive Officer, Director, Promoter
  • John Cornelius Thomas · Executive Officer, Director
  • Robert Gordon Matheny · Executive Officer, Director, Promoter
  • Blane Horton Crutchfield · Director
  • Jason Manouchehr Aryeh · Director
  • John Ellis Bush · Director
  • Richard Michael Ferrari · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “$702,000 paid to two independent directors as finders' fees.”

Signed by John C. Thomas, Secretary. Source: SEC Form D and 1 amendment, newest notice filed Oct 15, 2013. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Cormatrix Cardiovascular Inc. had revenue between $5 million and $25 million when it filed its newest notice of a funding round (Jan 2015).

    SEC Form D (revenue range) · Jan 2015

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Jan 2015

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Cormatrix Cardiovascular Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 2 rounds above had up to 34 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Cormatrix Cardiovascular Inc.
NameRoleNamed in
Beecher Chewing LewisExecutive officerJan 2015
David Bannerman CampExecutive officerJan 2015
John Cornelius ThomasExecutive officerJan 2015
Robert Gordon MathenyExecutive officerJan 2015
Beecher Chewing LewisDirectorJan 2015
Blane Horton CrutchfieldDirectorJan 2015
David Bannerman CampDirectorJan 2015
Jason M AryehDirectorJan 2015
John Cornelius ThomasDirectorJan 2015
Robert Gordon MathenyDirectorJan 2015
Jason Manouchehr AryehDirectorOct 2013
John Ellis BushDirectorOct 2013
Richard Michael FerrariDirectorOct 2013
David Bannerman CampPromoterJan 2015
Robert Gordon MathenyPromoterJan 2015